Respiratory Devices Market Size is USD 26.85 Billion in 2025

The global respiratory devices market size was valued at USD 25.35 billion in 2024, is projected to reach nearly USD 44.97 billion by 2034. Growing demand for advanced breathing support technologies and rising prevalence of respiratory disorders are driving its 5.9% CAGR.

Respiratory Devices Market Statical Scope

The respiratory supplies market is growing at a commendable pace due to the rising prevalence of respiratory diseases such as asthma, COPD, and pulmonary disorders.

The Indian Journal of Public Health data states that there are an estimated 37.8 million cases of COPD, contributing to 17.8% of the global burden of COPD and a disproportionate 27.3% to the global deaths. The main factor behind the rise of such diseases is pollution, smoking, and other factors, which create a huge demand for such supplies. These supplies primarily include devices and equipment for breathing support, such as oxygen therapy, airway management, and medication delivery. The aging factor also contributes to the rise in such diseases, as weakened lung function attracts a higher monitoring volume.

What Barriers Are Affecting Market Adoption?

The healthcare sector in rural and semi-urban areas lacks the adoption of such supplies due to limited financial availability. The respiratory supplies market in the area also lags due to a lack of professional expertise to handle CPAP and BiPAP systems in healthcare settings. The healthcare consumables market is also seeing several advancements in its supplies, which may lead to the adoption of high-cost equipment.

How Are Changing Lifestyles Influencing Market Demand?

The changing lifestyles in urban settings have led to a massive shift towards home care, creating a huge demand for portable, lightweight devices. Moreover, populations in semi-urban and urban settings can also adopt these supplies to enable more precise healthcare management. The healthcare sector is witnessing a surge in nebulizers and oxygen concentrators, which have been in high demand in recent years.

Which Regions Are Leading the Respiratory Supplies Market?

The governments in the U.S. and Canada invest heavily in the healthcare consumables market to manage various diseases, including respiratory diseases. Additionally, the region sees more companies investing in advanced technologies and materials to drive growth in the respiratory supplies market. Asia Pacific is considered one of the most opportunistic regions due to healthcare advancements in Japan, China, and India. Additionally, the region is focusing on improving its manufacturing base, which will reduce reliance on imports and lower equipment costs.

How Are AI and ML Technologies Transforming the Market?

The use of artificial intelligence AI and machine learning ML in these respiratory devices is expected to bring several improvements, as systems analyze respiratory patterns and detect failures in real time through monitors and ventilators. Additionally, the data analysis capability predicts further failures, which can help manage the patient's diagnostic procedure. These technologies are expected to help drive smart home monitoring devices at a rapid pace.

Respiratory Devices Market Share, By Region, 2024 (%)

• North America – Holds 35% of the market, driven by advanced healthcare systems and high adoption of respiratory technologies. Dominates due to strong reimbursement frameworks and high COPD and sleep apnea prevalence.
• Europe – Accounts for 30% of the market, supported by robust clinical infrastructure. Gaining momentum with increased focus on chronic respiratory disease management.
• Asia Pacific – Represents 25% of the market, fueled by large patient populations and increasing healthcare investment. Gaining momentum as respiratory device adoption accelerates.
• LAMEA – Holds 10% of the market, with emerging but slower-growing demand. Not dominating due to limited access to advanced respiratory care technologies.

Respiratory Devices Market Share, By Type, 2024 (%)

• Therapeutic Devices – Hold 55% of the market, forming the core category used for treating respiratory conditions. Dominates today but sees a very slight decline over time as diagnostic technologies gain traction.
• Diagnostic & Monitoring Devices – Account for 25% of the market, supporting detection and continuous monitoring of respiratory disorders. Gaining momentum as adoption increases, allowing the segment to gradually gain share over the forecast period.
• Consumables and Accessories – Represent 20% of the market, including masks, tubing, filters, and other recurring-use items. Stay broadly stable over time due to consistent demand tied to device usage.

Respiratory Devices Market Share, By Application, 2024 (%)

• COPD – Represents 35% of the market, driven by the high global prevalence of chronic obstructive pulmonary disease. Dominates today but slowly loses a bit of share as Sleep Apnea and Asthma treatments expand.
• Sleep Apnea – Holds 25% of the market, supported by rising diagnosis rates and increased CPAP/BiPAP usage. Gaining momentum and gradually capturing share from COPD.
• Asthma – Accounts for 15% of the market, fueled by growing awareness and improved treatment access. Gains some share over time as asthma device adoption increases.
• Infectious Diseases – Represents 15% of the market, especially relevant for respiratory infections requiring ventilation or monitoring. Stable but not dominating compared to chronic conditions.
• Others – Make up 10% of the market, consisting of miscellaneous respiratory disorders. Not dominating due to smaller patient groups.

Respiratory Devices Market Share, By End-User, 2024 (%)

• Hospitals and ASCs – Hold 45% of the market, serving as the primary centers for acute respiratory care. Dominates due to high patient volumes and availability of advanced respiratory technologies.
• Specialty Clinics – Account for 25% of the market, focusing on pulmonology and respiratory care. Stable but not dominating due to narrower service scope.
• Home Care Settings – Also represent 25% of the market, covering home-based ventilation, oxygen therapy, and sleep apnea devices. Gaining momentum as remote and at-home respiratory care adoption rises.
• Others – Comprise 5% of the market, including rehabilitation centers and emergency facilities. Not dominating due to limited usage volume.

Respiratory Devices Market Companies

• Koninklijke Philips N.V. (Netherlands)
• Medtronic (Ireland)
• ResMed, Inc. (U.S.)
• Fisher & Paykel Healthcare Limited (New Zealand)
• Masimo (U.S.)
• Getinge AG (Sweden)
• GE HealthCare (U.S.)
• Baxter (U.S.)

Respiratory Devices Market Segmentation

By Type

• Therapeutic Devices
• Diagnostic & Monitoring Devices
• Consumables and Accessories

By Application

• Chronic Obstructive Pulmonary Disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Others
  

By End-User

• Hospitals and ASCs
• Specialty Clinics
• Home Care Settings
• Others
  

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa